Refractory Lymphoma

Irinotecan In Relapsed Or Refractory Non-Hodgkin’s Lymphomas
Administered at 300 mg/m² every 21 days[11] in patients with relapsed or refractory non-Hodgkin’s lymphoma (NHL). Patients and Methods Eligibility Criteria Patients were eligible for study entry if they had histologically confirmed relapsed or refractory NHL. ... Document Retrieval

Relapsed And Refractory Hodgkin Lymphoma - YouTube
In this segment, Anas Younes, MD, and John Sweetenham, MD, discuss treatment of relapsed and refractory Hodgkin lymphoma. ... View Video

Mantle Cell lymphoma - Wikipedia, The Free Encyclopedia
Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma (NHL), comprising about 6% of NHL cases. There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.) MCL is difficult to treat and seldom considered cured. Median survival times ... Read Article

REFRACTORY CD30+ LYMPHOMA - European Medical Journal
66 HEMATOLOGY • July 2014 EMJ EUROPEAN MEDICAL JOURNAL HEMATOLOGY • July 2014 EMJ EUROPEAN MEDICAL JOURNAL 67 Management of relapsing or refractory sALCL ... Fetch Here

Relapsed And Refractory Hodgkin Lymphoma
Relapsed and Refractory Hodgkin Lymphoma Lymphoma Overview Lymphoma is a cancer of the white blood cells, namely lymphocytes, which constitute the lymphatic system. ... Read More

The Battle Against Refractory Lymphomas: Guerrilla Warfare ...
The treatment of recurrent and refractory lymphoma is as heterogenous as the disease itself. Considerable con- troversy surrounds the choice of therapy for patients with intermediate grade lymphoma in first relapse. A telephone ... Access This Document

Allogeneic Bone Marrow Transplantation For Relapsed And ...
Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma EJ Dann, CK Daugherty and RA Larson One patient died from refractory or relapsing lymphoma has yet to be defined. ... Fetch Document

Rescue Therapy For Canine Lymphoma - Clinician's Brief
Rescue Therapy for Canine Lymphoma Chemotherapy failure is an obstacle veterinarians frequently encounter when treating non-Hodgkin’s lymphoma in dogs. ... Access This Document

TetraLogic Reports Third Quarter Financial Results And Provides Clinical Programs Update
MALVERN, Pa. -- TetraLogic Pharmaceuticals Corporation , a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, ... Read News

Refractory Celiac Disease: What Is It? What To Do?
Refractory celiac disease (sometimes called . refractory sprue) should be considered. diet is rarely due to refractory disease or . lymphoma. Other explanations are much more likely. A repeat small intestinal biopsy is often ... Read Full Source

Long-Term Effects Of High-Dose Chemotherapy And Radiation For ...
Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin Lymphoma Karyn A. Goodman,1 Elyn Riedel,2 Victoria Serrano,2 ... Retrieve Content

Lymphoma/Myeloma News - MD Anderson
Lymphoma/Myeloma News MD Anderson Clinical Trials Advancing Research in Lymphoma/Myeloma and Refractory Lymphoma and T PI: Yasuhiro Oki, MD PI: Michelle Fanale, MD may also affect cell signaling and traf-This investigator-initiated trial is de- ... Access Document

Follicular Lymphoma: Relapsed/Refractory
Follicular Lymphoma: Relapsed/Refractory Overview Lymphoma is the most common blood cancer. The two main forms of lymphoma are Hodgkin lymphoma (HL) and non-Hodgkin ... Access Full Source

Non-Hodgkin lymphoma - Oncology Ex
Oe VOL. 12, NO. 1, February 2013 43 landmarks non-Hodgkin lymphoma r-GDP LeSS TOXIC THaN r-DHaP IN reLaPSeD/reFraCTOry NHL Douglas Stewart, MD, FRCPC, Chief, Division of Hematology & Hematological Malignancies, university of Calgary. ... Fetch Document

How I Treat Relapsed And refractory Hodgkin lymphoma
2 ABSTRACT Relapsed or refractory Hodgkin lymphoma is a challenging problem for clinicians who treat hematological malignancies. The standard management of these patients should ... Access Document

Diffuse Large B-cell lymphoma - Wikipedia, The Free Encyclopedia
Diffuse large B-cell lymphoma (DLBCL or DLBL) is a cancer of B cells, a type of white blood cell responsible for producing antibodies. It is the most common type of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year. ... Read Article

The New England Journal Medicine
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma Ibrutinib in Mantle-Cell Lymphoma n engl j med 369;6 nejm.org august 8, 2013 509 for the compilation of this report. Manuscript drafts were prepared by all the authors, with edi- ... Doc Viewer

Juno Therapeutics To Report Third Quarter 2015 Financial Results On Tuesday, November 10
Juno Therapeutics, Inc. will announce financial results for the third quarter of 2015 on Tuesday, November 10, 2015, after the close of U.S.-based financial markets. Following the announcement, Juno management will host a conference call and live webcast to provide a business update and discuss financial results beginning at 2:00 p.m. ... Read News

New Leukemia Drug Imbruvica - About.com Health
Imbruvica will help some with relapsed or refractory leukemia. By Naveed Saleh, MD, MS. Medical Treatments Expert Share Pin Tweet Submit Stumble Post Share issued the drug fast-tracked or breakthrough therapy designation for Waldenström’s macroglobulinemia and mantle cell lymphoma. ... Read Article

Janssen To Showcase Growing Portfolio With More Than 40 Data Presentations At The 2015 American Society Of Hematology ...
RARITAN, N.J., Nov. 5, 2015 /PRNewswire/ -- At the 57 th American Society of Hematology (ASH) Annual Meeting , Janssen Research & Development, LLC will present new data for both approved and investigational ... Read News

Brentuximab For Refractory CD30+ Hodgkin’s Lymphoma: Clinical ...
TITLE: Brentuximab for Refractory CD30+ Hodgkin’s Lymphoma: Clinical and Cost-Effectiveness . DATE: 23 April 2013 . RESEARCH QUESTIONS . 1. What is the clinical effectiveness of brentuximab for patients with refractory CD30+ ... Get Content Here

REVLIMID (lenalidomide) Relapsed/refractory Newly Diagnosed
Mantle cell lymphoma: Relapsed/refractory (US) Mantle cell lymphoma: Relapsed/refractory (EU) Diffuse large B-cell: Maintenance Diffuse large B-cell (ABC-subtype): First-line CLG1502 Q3 Corporate Pipeline-1 D3V1 Created Date: ... Fetch Here

Bendamustine For Relapsed Follicular lymphoma
Bendamustine for relapsed follicular lymphoma refractory to rituximab January 2013 London Cancer New Drugs Group Background Follicular lymphoma is the most common subtype of ... Read Content

Guideline On The Management Of Primary Resistant And Relapsed ...
1 Guideline on the Management of Primary Resistant and Relapsed Classical Hodgkin Lymphoma. On behalf of the British Committee for Standards in Haematology, and the British ... Return Document

GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) For ...
GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory Lymphoma Page 2 of 4 Reason for Update: Network Protocol Development Approved by Consultant: P Fields 29/03/2012 ... Retrieve Here